Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Surgery Plus Single Course Methotrexate Versus Primary Methotrexate for Treatment of Gestational Trophoblastic Neoplasms in Low Risk Cases Above 40y: a Randomized Controled Trial

NCT02606539 is registered in ClinicalTrials.gov with Maher elesawi kamel elesawi as lead sponsor.

NCT NCT02606539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02606539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Surgery Plus Single Course Methotrexate Versus Primary Methotrexate for Treatment of Gestational Trophoblastic Neoplasms in Low Risk Cases Above 40y: a Randomized Controled Trial
Lead sponsor
Maher elesawi kamel elesawi
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 30, 2015
Completion date
August 31, 2017
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gestational trophoblastic neoplasms